Insulin aspart, recombinant Subcutaneous and Optiray 240
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Optiray 240 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ioversol
Brand name: Optiray 240, Optiray 300, Optiray 320, Optiray 350, Optiray 160
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Optiray 300
- Insulin aspart, recombinant Subcutaneous-Optiray 320
- Insulin aspart, recombinant Subcutaneous-Optiray 350
- Insulin aspart, recombinant Subcutaneous-Optison
- Insulin aspart, recombinant Subcutaneous-Optivar
- Insulin aspart, recombinant Subcutaneous-Optivite P.M.T.
- Optiray 240-Insulin degludec
- Optiray 240-Insulin Degludec (U-100) Prefilled Pens
- Optiray 240-Insulin Degludec (U-100) Vials
- Optiray 240-Insulin Degludec (U-200) Prefilled Pens
- Optiray 240-Insulin degludec and liraglutide
- Optiray 240-Insulin degludec and liraglutide Subcutaneous